Immunocore Holdings PLC Sponsored ADR IMCR
30.72
(0.57)
(1.82%)
as of 25 Sep
- Market cap
- $1.6B
- P/E
- 0.0×
Follow IMCR
Growth Flags
show if company had growth for consecutive years
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 0.00 | 0.00 | 0.00 | 39.89 | 14.53 | 14.04 | 4.75 | 4.37 |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 70.45 | 0.00 |
P/Operating CF |
— | 0.00 | 0.00 | 0.00 | (65.67) | (218.22) | (197.51) | (105.71) | (53.51) |
P/B ratio |
— | 0.00 | 0.00 | 0.00 | 6.17 | 7.48 | 9.50 | 4.09 | 4.59 |
Price to Tangible BV |
— | 0.00 | 0.00 | 0.00 | 6.17 | 7.49 | 9.55 | 4.11 | 4.61 |
EV/Sales |
— | 0.00 | 0.00 | 0.00 | 33.33 | 12.51 | 12.46 | 3.53 | 3.31 |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | 0.00 | 0.00 | 0.00 | (9.20) | (44.32) | 1,057.51 | 41.96 | (123.66) |
EV/FCF |
— | 0.00 | 0.00 | 0.00 | (9.11) | (42.42) | (1,251.14) | 52.24 | (88.01) |
Quick Ratio |
— | 3.44 | 1.47 | 2.78 | 4.29 | 4.32 | 3.56 | 4.16 | 3.81 |
Current Ratio |
— | 3.45 | 1.47 | 2.78 | 4.29 | 4.70 | 3.80 | 4.38 | 4.04 |
Net Debt/EBITDA |
— | 1.14 | 0.15 | 0.85 | 1.36 | 7.61 | 7.10 | 6.48 | 11.19 |
Debt/Assets |
0.00% | 9.64% | 30.95% | 32.46% | 21.15% | 9.43% | 8.04% | 38.73% | 36.83% |
Debt/Equity |
— | 0.33 | 3.89 | 1.16 | 0.37 | 0.15 | 0.13 | 1.08 | 1.03 |
Asset Turnover |
— | 0.25 | 0.13 | 0.16 | 0.11 | 0.37 | 0.44 | 0.39 | 0.39 |
Operating CF/Net income |
— | 0.23 | 0.98 | 0.82 | 0.73 | 0.94 | (0.05) | (0.51) | 0.30 |
Capex/Depreciation |
— | 0.00 | (0.46) | (0.27) | (0.13) | (0.51) | (1.33) | (1.22) | (1.33) |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | (208.47%) | (291.91%) | (211.59%) | (117.84%) | (18.28%) | (15.62%) | (14.00%) | (9.58%) | |
| — | (76.61%) | (54.57%) | (38.81%) | (54.14%) | (11.16%) | (9.84%) | (6.36%) | (3.42%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
— | (52.65%) | (109.81%) | (66.34%) | (62.48%) | (13.79%) | (13.86%) | (7.02%) | (4.66%) |
Average Days of Receivables |
— | 679.12 | 711.67 | 281.38 | 341.88 | 70.30 | 76.23 | 74.14 | 69.16 |
Research and Development Expense of Revenue |
— | 354.33% | 389.54% | 248.42% | 276.12% | 58.45% | 65.57% | 71.61% | 68.71% |
Selling, General and Administrative Expense of Revenue |
— | 120.42% | 172.13% | 151.89% | 333.33% | 70.58% | 57.93% | 50.22% | 41.35% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | 0.00% | 11.91% | 27.10% | 135.22% | 18.86% | 13.02% | 11.02% | 9.42% |
Graham Net Nets |
— | 0.00 | 0.00 | 0.00 | 0.13 | 0.11 | 0.09 | 0.19 | 0.18 |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (3.63%) | (3.63%) | (3.63%) | (12.41%) | (2.04%) | (1.65%) | (3.46%) | (2.03%) |
Free Cash Flow Yield |
— | 0.00% | 0.00% | 0.00% | (9.17%) | (2.03%) | (0.07%) | 1.42% | (0.86%) |
Revenue per Share |
— | 0.00 | 7.35 | 1.46 | 0.86 | 3.81 | 5.10 | 6.21 | 7.95 |
Operating CF per Share |
— | 0.00 | (29.03) | (2.93) | (3.11) | (1.08) | 0.06 | 0.52 | (0.21) |
Capex per Share |
— | 0.00 | (1.20) | (0.12) | (0.03) | (0.06) | (0.11) | (0.10) | (0.09) |
Free Cash Flow per Share |
— | 0.00 | (30.23) | (3.05) | (3.14) | (1.14) | (0.05) | 0.42 | (0.30) |
Cash per Share |
— | 0.00 | 21.25 | 6.28 | 7.70 | 8.80 | 9.05 | 16.41 | 17.16 |
Shareholders Equity per Share |
— | 0.00 | 4.23 | 2.68 | 5.55 | 7.41 | 7.54 | 7.22 | 7.57 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.00 | 4.23 | 2.68 | 5.55 | 7.41 | 7.54 | 7.22 | 7.57 |
Free Cash Flow |
— | (22.17) | (134.80) | (80.86) | (133.44) | (51.91) | (2.48) | 20.93 | (15.05) |
Working Capital |
— | 154.84 | 50.78 | 125.75 | 277.15 | 373.14 | 389.80 | 717.68 | 750.05 |
Capital Expenditures |
— | (4.72) | (5.36) | (3.08) | (1.28) | (2.70) | (5.42) | (5.13) | (4.34) |
Net Current Asset Value |
— | 40.74 | (59.50) | 14.23 | 182.20 | 286.12 | 300.66 | 281.07 | 310.51 |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.00 | 0.16 | 0.08 | 0.04 | 0.02 | 0.02 | 0.02 | 0.01 |
Net Profit Margin |
— | (302.82%) | (404.89%) | (246.04%) | (495.94%) | (30.13%) | (22.17%) | (16.47%) | (8.88%) |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | 0.34 | 0.17 | 0.65 | 0.78 | 0.68 | 0.44 | 0.42 | 0.28 |
Cash ROIC |
— | (19.16%) | (106.69%) | (29.84%) | (22.20%) | (7.21%) | (0.73%) | 1.02% | (1.35%) |
Accounts Receivable Turnover |
— | 0.50 | 0.53 | 0.83 | 1.14 | 5.15 | 5.82 | 5.39 | 5.76 |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.06 | 0.13 | 0.21 |
Inventory Turnover |
— | — | — | — | — | 0.00 | 0.40 | 0.55 | 0.83 |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | 0.00 | 4,843.20 | 6,264.48 | 3,354.63 | 1,748.15 |
Days of Inventory on Hand |
— | — | — | — | — | 231.94 | 1,584.25 | 727.86 | 483.75 |
Average Receivables |
— | 62.49 | 61.30 | 46.86 | 31.98 | 33.87 | 42.84 | 57.55 | 69.40 |
Average Payables |
— | 14.52 | 22.94 | 35.35 | 40.88 | 31.59 | 16.12 | 21.45 | 24.73 |
Average Inventory |
— | — | — | — | — | — | 2.60 | 4.97 | 6.09 |
Average Assets |
— | 124.67 | 243.20 | 245.13 | 334.08 | 470.87 | 561.88 | 803.25 | 1,038.39 |
Average Common Equity |
— | 45.82 | 45.46 | 44.96 | 153.48 | 287.40 | 353.87 | 364.78 | 370.87 |
Columns are period end dates